HHS to allow sale of unapproved peptides under review
Summary
The Department of Health and Human Services said it will use enforcement discretion to allow compounding pharmacies to make and sell certain peptides that are not yet on the approved-substances list. The move advances access to peptides associated with the Make America Healthy Again agenda.Key Facts
- HHS announced its decision in a notice.
- The policy concerns peptides not yet added to the list of approved substances.
- Compounding pharmacies will be allowed to manufacture and sell the peptides under enforcement discretion.
- The article links the change to the Make America Healthy Again agenda.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
